Bone Marrow Suppression in the Setting of Normal Thiopurine Methyltransferase Phenotype Testing

被引：1
作者：
Best, Chad [1 ]
Sudel, Boris [1 ]
机构：
[1] Univ Minnesota, Dept Pediat, Div Pediat Gastroenterol & Nutr, Minneapolis, MN 55455 USA
来源：
CLINICAL PEDIATRICS | 2010年 / 49卷 / 09期
关键词：
INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; ULCERATIVE-COLITIS; AZATHIOPRINE; 6-MERCAPTOPURINE; TOXICITY; MYELOSUPPRESSION; THERAPY; ANEMIA;
D O I：
10.1177/0009922809335739
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页码：901 / 903
页数：3
相关论文
共 22 条
  • [1] ABELOFF MD, 2004, CLIN ONCOLOGY, P534
  • [2] LOW-DOSE 6-MERCAPTOPURINE IN INFLAMMATORY DOWEL DISEASE IS ASSOCIATED WITH MINIMAL HEMATOLOGIC TOXICITY
    BERNSTEIN, CN
    ARTINIAN, L
    ANTON, PA
    SHANAHAN, F
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (08) : 1638 - 1641
  • [3] Leukopenia and thrombocytopenia as adverse effects of treatment with 5-aminosalicylic suppositories
    Casellas, F
    Vallano, A
    Malagelada, JR
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1996, 22 (02) : 160 - 161
  • [4] Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
    Colombel, JF
    Ferrari, N
    Debuysere, H
    Marteau, P
    Gendre, JP
    Bonaz, B
    Soulé, JC
    Modgliani, R
    Touze, Y
    Catala, P
    Libersa, C
    Broly, F
    [J]. GASTROENTEROLOGY, 2000, 118 (06) : 1025 - 1030
  • [5] BONE-MARROW TOXICITY CAUSED BY AZATHIOPRINE IN INFLAMMATORY BOWEL-DISEASE - 27 YEARS OF EXPERIENCE
    CONNELL, WR
    KAMM, MA
    RITCHIE, JK
    LENNARDJONES, JE
    [J]. GUT, 1993, 34 (08) : 1081 - 1085
  • [6] Dose-dependent influence of 5-aminosalicylates on thiopurine metabolism
    de Boer, Nanne K. H.
    Wong, Dennis R.
    Jharap, Bindia
    de Graaf, Peer
    Hooymans, Piet M.
    Mulder, Chris J. J.
    Rijmen, Frank
    Engels, Leopold G. J. B.
    van Bodergraven, Adrian A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (12) : 2747 - 2753
  • [7] On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients
    de Boer, Nanne K. H.
    Derijks, Luc J. J.
    Gilissen, Lennard P. L.
    Hommes, Daniel W.
    Engels, Leopold G. J. B.
    de Boer, Sybrand Y.
    den Hartog, Gijsbertus
    Hooymans, Piet M.
    Makelburg, Anja B. U.
    Westerveld, Barend D.
    Naber, Anton H. J.
    Mulder, Chris J. J.
    de Jong, Dirk J.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (35) : 5540 - 5544
  • [8] Interaction between azathioprine and aminosalicylates:: an in vivo study in patients with Crohn's disease
    Dewit, O
    Vanheuverzwyn, R
    Desager, JP
    Horsmans, Y
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (01) : 79 - 85
  • [9] Azathioprine myelosuppression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphisms
    Frohman, EM
    Havrdova, E
    Levinson, B
    Slanar, O
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2006, 12 (01) : 108 - 111
  • [10] Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease
    Gearry, RB
    Barclay, ML
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (08) : 1149 - 1157
123